Accelerator Startups
The Cohort 2024 Accelerator startups represent some of the most progressive leaders driving digital innovation in oncology. Their novel ideas were selected from over 100 applications, and they worked with CancerX Champions, Mentors, and members across the healthcare ecosystem to test and validate their solutions. We’re proud of the diverse representation of our cohort: close to 20% of companies are international, 75% of our founders are women or BIPOC, and 12 of 16 are first-time founders!
By graduating from the Accelerator program, these startups have a roadmap to successfully scale their company, an opportunity to move forward with their sponsor, and a strong community supporting their development. With 16 empowered startups poised for success and equipped with the tools and expertise needed to bring their ideas to life, significant strides are being made in revolutionizing the fight against cancer through digital innovation.
Blue Box
See More Details
Company Name: The Blue Box
Location: United States
Profile: Low-cost breast cancer test from a urine sample, 30% more sensitive than mammography, and non-age dependant.
Representative: Judit Giró Benet
Socials:
C the Signs
See More Details
Company Name: C the Signs
Location: United Kingdom
Profile: C the Signs™ is an AI cancer prediction platform identifying patients at risk of cancer at the earliest & most curable stage of the disease.
Representative: Bea Bakshi
Socials:
Cancer Insights
See More Details
Company Name: Cancer Insights
Location: United States
Profile: Cancer Insights delivers an AI driven and EMR integrated oncology clinical workflow to providers to reduce care burden and improve outcomes.
Representative: Tarun Kumar
Socials:
Curiva
See More Details
Company Name: Curiva
Location: United States
Profile: CurivaTM is commercializing a non-invasive wearable diagnostic patch for gynecologic malignancies detection - diaPatchTM.
Representative: Eydis Lima
Socials:
EnteroTrack
See More Details
Company Name: EnteroTrack
Location: United States
Profile: EnteroTrack is a clinical-stage, platform technology company that provides simple, scalable, yet comprehensive solutions to monitor and screen for upper GI diseases. Unlike endoscopy or cellular-brushing, our clinically validated method can be used with no discomfort in an office or home setting, is suitable for adults and children, and provides quantitative measures of disease activity, all of which help patients better understand and control chronic upper GI diseases.
Representative: Robin Shandas
Socials:
Gesund.ai
See More Details
Company Name: Gesund.ai
Location: United States
Profile: Gesund is the world’s first AI assurance lab on a mission to help bring clinical-grade AI solutions to market. To help comply with regulatory requirements, our platform audits and validates 3rd party medical AI solutions for safety, effectiveness and equity. Backed by marquee investors including Merck, McKesson, Northpond and 500, Gesund orchestrates the entire AI/ML lifecycle for all stakeholders by bringing models, data and experts together in a no-code environment.
Representative: Enes Hosgor
Socials:
Gray Oncology
See More Details
Company Name: Gray Oncology
Location: Canada
Profile: Gray envisions a resource-optimal healthcare system with GrayOS - an operating system that optimizes and automates cancer care logistics.
Representative: Andre Diamant
Socials:
LIND AI
See More Details
Company Name: LIND AI
Location: United States
Profile: LIND AI scales clinical trial operational efficiency with AI-enabled data abstraction, with transparency, evidence and document linkage.
Representative: Ognjen Nikolic
Socials:
Mika Health
See More Details
Company Name: Mika Health
Location: Germany
Profile: Mika is Europe's largest Oncology Digital Therapeutic, having treated over 100,000 patients with our Class II MDR approved SaMD.
Representative: Mark Slaughter
Socials:
Navya
See More Details
Company Name: Navya
Location: United States
Profile: Navya cancer data model serves oncologists and patients in three ways: create meaning from complex medical records; generate actionable, billable draft clinical notes with effective treatment planning; and translate medical jargon into patient understandable language. These workflow transformations drive efficiencies, enhance quality of care, and patient satisfaction. Navya is a clinically validated solution used by cancer centers like Memorial Sloan Kettering and Tata Memorial Center.
Representative: Naresh Ramarajan
Socials:
Oatmeal Health
See More Details
Company Name: Oatmeal Health
Location: United States
Profile: Oatmeal Health is a technology-driven cancer screening provider designed to identify individuals at high risk, provide extensive care navigation, and conduct radiology risk assessments. Our primary initiative targets community health centers and health plans.
Representative: Jonathan Govette
Socials:
Orbit Genomics
See More Details
Company Name: Orbit Genomics
Location: United States
Profile: Orbit Genomics' patent pending OrbiSeq platform is transforming cancer diagnosis, treatment, and prevention through early warning genomics.
Representative: Dede Willis
Socials:
Realyze Intelligence
See More Details
Company Name: Realyze Intelligence
Location: United States
Profile: Realyze Intelligence is a software company that accelerates the clinical trial enrollment and collection of Real-World Data for health systems and cancer centers. The solution automates the screening and matching of patients, enabling organizations to increase enrollment, target more diverse populations and expand clinical research capabilities using existing resources. The Realyze platform leverages a combination of clinical expert modeling and AI to analyze EHR data in real time.
Representative: Gilan ElSaadawi
Socials:
Reimagine Care
See More Details
Company Name: Reimagine Care
Location: United States
Profile: We believe people living with cancer deserve a better patient experience; to feel their best and to spend as much time as possible with the people they love, doing the things that bring them joy.
Representative: Scott Eising
Socials:
Survivor Plan
See More Details
Company Name: Survivor Plan
Location: United States
Profile: SurvivorPlan's digital health tools support high-quality survivorship care, helping care teams address each individual patient's needs.
Representative: Elaine Warren
Socials:
Xanthos Health
See More Details
Company Name: Xanthos Health
Location: United States
Profile: XanthosHealth: Redefining cancer care with a digital social care referral platform, connecting patients to real-time support services.
Representative: Pinar Karaca Mandic
Socials:
Sign up to be the first to hear about details for Cohort 2025
After the incredible success of the first Cohort, we are thrilled to offer organizations the chance to be involved in our next cohort! Submissions for Cohort 2025 will open this fall, and if you want to join the CancerX Accelerator as a Startup, Champion, or Mentor, sign up for updates and be among the first to learn more about Cohort 2025.
